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Cellular homeostasis in the B cell compartment is strictly imposed to balance cell
production and cell loss. However, it is not clear whether B cell development in the bone
marrow is an autonomous process or subjected to regulation by the peripheral B cell
compartment. To specifically address this question, we used mice transgenic for human
CD20, where effective depletion of B lineage cells is obtained upon administration of
mouse anti-human CD20 antibodies, in the absence of any effect on other cell lineages
and/or tissues. We followed the kinetics of B cell return to equilibrium by BrdU labeling and
flow cytometry and analyzed the resulting data by mathematical modeling. Labeling was
much faster in depleted mice. Compared to control mice, B cell-depleted mice exhibited
a higher proliferation rate in the pro-/pre-B compartment, and higher cell death and lower
differentiation in the immature B cell compartment. We validated the first result by analysis
of the expression of Ki67, the nuclear protein expressed in proliferating cells, and the
second using Annexin V staining. Collectively, our results suggest that B lymphopoiesis
is subjected to homeostatic feedback mechanisms imposed by mature B cells in the
peripheral compartment.
Keywords: B lymphocytes, BrdU, computer simulation, homeostatic feedback, mathematical modeling
INTRODUCTION
B cell development starts in the bone marrow (BM) and continues in the spleen to final maturation.
Developmental progression is guided by sequential events leading to assembly, expression, and
signaling of the B cell antigen receptor (BCR). Heavy (H) and light (L) chain immunoglobulin genes
are rearranged at the pro-B and pre-B stages (respectively), and complete surface IgM is expressed at
the immature stage (1–5). Further developmental progression and maturation in the periphery are
limited by positive and negative selection,mediated by BCR signaling and aiming to construct a non-
self-reactive, immune-competent repertoire of naïve B cells (2, 6). In the adult mouse, the number of
mature B cells remains constant, despite continuous production of new cells in the BM. It has been
estimated that 1–2 107 immature B cells are generated daily in the adultmouse and leave the BM as
transitional B cells (7), but only about 3% enter the pool ofmature B cells (8). Another source of B cell
input to the peripheral compartment is antigen-driven proliferation. Cell death due to several factors
including self-reactivity (9), incomplete maturation (10), competition for follicular niches (11), and
trophic mediators (12) limits the size of the peripheral compartment. Thus, the balance between cell
production and cell death maintains the size of the peripheral B cell compartment unchanged (13).
Abbreviations: AIC, Akaike’s information criterion; BCR, B cell antigen receptor; BM, bone marrow; LHS, Latin hypercube
sampling; MLE, maximum likelihood estimator.
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To understand this homeostatic control, it is of critical impor-
tance to quantify the rate of B lymphopoiesis under physiological
conditions. This question has been the subject of several investi-
gations in the past, employing different approaches. Experiments
based on an irradiation/autoreconstitution model of marrow-
derived B cell differentiation demonstrated that frequencies of
pro-/pre-B cells (14, 15) and immature B cells (16) increase after
irradiation, and so does differentiation and maturation (17, 18). It
has also been demonstrated that upon immunological challenge,
BM B lymphopoiesis increases, as measured by cell number, cell
division, and turnover (19, 20). These experiments supported the
concept that B lymphopoiesis is regulated by a feedback mecha-
nism imposed by peripheral B cells and/or environmental stimuli.
Other experiments have used mixed BM chimeras to suggest
that B cell production in the BM is not subjected to feedback
inhibition by the peripheral B cell compartment but is rather
autonomously regulated (21, 22). Similarly, in mice depleted of
B cells from birth by anti-IgM antibodies, or in hematologically
mutant mice (20), no difference was found in the proliferation
rate of pre-B cells relative to controls. There are also contradicting
results about the influence of serum immunoglobulins on the
regulation of developing B cell populations in the BM (23, 24).
Possible causes for the different conclusions may be attributed
to the profound differences in the experimental systems used to
eliminate the peripheral B cell compartment and to the complexity
of both models in affecting other lineages and tissues. Moreover,
quantification of B cell production in each of the above studies
was based on a single measurement of cell frequency, which may
be differentially affected in each experimental setup, rather than
on a series of kinetic measurements. Thus, while the concept that
B cell homeostasis is mediated through a feedback effect exerted
by peripheral B cells on developing B cells has been proposed
earlier (14, 15), it has not yet been proven. In order to address this
question, we have used the human CD20Tg mouse model, where
peripheral B cells can be specifically eliminated using anti-hCD20
antibodies with no residual effect on other cell populations (25),
in a study combining BrdU labeling over time and mathematical
modeling.
Mathematical models are often used to extract parameters
from labeling experiments for better interpretations of the results,
which otherwise are very often misinterpreted (26, 27). We have
previously used the combination of BrdU labeling and mathe-
matical models to study the development and maturation of B
cells (28–30). These studies led to the discoveries of phenotypic
reflux in B cell development (28) and the role of the Transitional-
3 compartment as an anergic pool accounting for most follicular
mature B cell death in WT mice (30) showed that, in contrast, in
Lyn /  mice, the less stable follicular B cells died directly (31).
In the present study, we asked whether or not the rate of B
lymphopoiesis is increased upon demand for peripheral B cells.
To address this issue, we expanded our previous mathematical
model to include the mature recirculating subpopulation in the
BM and fit the model to data from BrdU labeling experiments on
B cell-depleted and control mice. We report here that the rapid
reconstitution of marrow B cell numbers after short depletion is
due to increased proliferation in the pro-/pre-B cell compartment.
BM subpopulations were reconstituted faster than subpopulations
that develop in the spleen. The depletion also strongly affected
the immature B cell subset; we found accelerated immature B cell
death and lower rates of differentiation to transitional B cells in
depleted mice compared to control mice. Finally, our new mathe-
matical model, which includes the subset of mature recirculating
B cells in the BM, predicts that themost probable source ofmature
B cells in the BM is inflow from the periphery to the BM, rather
than from developing B cells.
MATERIALS AND METHODS
Mice and B Cell Depletion
For these experiments, we used Balb/c mice that are normal or
transgenic for human CD20 (hCD20 Tg) (25) at 3–4months of
age. The mice were housed and bred at the animal facility of the
Faculty of Medicine, Technion, and all studies were approved by
the institute’s committee for the supervision of animal experi-
ments. To deplete B cells in vivo, hCD20Tg mice were injected
intraperitoneally with purified monoclonal mouse anti-hCD20
(clone 2H7) antibodies at 1mg/mouse as described (25). Deple-
tion was confirmed by flow cytometry analysis of peripheral
blood cells. Mice were analyzed 34 days after depletion, when
reconstitution of peripheral compartment reached 50–60% (32).
Antibodies and Flow Cytometry Analysis
Isolation, staining, and flow cytometry analysis for B cell
populations in BM and spleen were carried out as described
earlier (32–34). Briefly, single-cell suspensions from BM
and spleen were stained for surface marker expression using
PE-, allophycocyanin-, PerCP-, and biotin-conjugated Abs,
visualized with Streptavidin Brilliant Violet 421 (BioLegend).
Antibodies used for cell staining were CDR45R/B220 RA3-
6B2 (BioLegend), CD23 clone 2G8 [Southern Biotechnology
Associates (SBA)], CD43 clone S7 (BD Biosciences), CD93
(AA4.1) (eBioScience), human CD20 (hCD20) clone 2H7
(eBioscience), and IgM (Jackson ImmunoResearch). Stained cells
were analyzed by a fluorescence-activated cell sorter (FACS)
with viable lymphocyte gate as defined by forward and side
light scatter. Data for five-color analysis were collected on a
FACSCyAn ADP (Beckman Coulter Inc.) and were analyzed
using the FlowJo software (Tree Star). B cell subsets were defined
using the following surface markers: in the BM: pro-/pre-B cells
(B220+/AA4.1 /IgM ), immature (B220+/AA4.1+/IgM+),
and mature-circulated (B220+/AA4.1 /IgM+); in the
spleen: transitional (B220+/AA4.1+/IgM+) and mature
(B220+/AA4.1 /IgM+), as described in Ref. (32–36).
Analysis of BrdU Incorporation
In vivo BrdU incorporation was performed as described (28).
Briefly, mice were intraperitoneally injected with two doses per
day of 2mg/mouse of BrdU. On days 2, 4, and 7, BM and spleen
cells were isolated and stained with fluorescently labeled antibod-
ies for surface markers, as detailed in the previous section. Sub-
sequently, cells were stained with a FITC-conjugated anti-BrdU
antibody using the BrdU Flow Kit (BD Biosciences), according to
the manufacturer’s protocol.
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Analysis of Ki67 Expression
B cell proliferation was estimated in control and B cell-depleted
mice 21 days after B cell depletion by flow cytometry using an
intracellular antibody against Ki67, the nuclear protein expressed
in proliferating cells, as described in Ref. (37). For determination
of Ki67-positive cells, cells were first stained for surface B cells
markers: B220, AA4.1, and IgM, followed by intracellular stain-
ing for Ki67 as follows. Cells were fixed and permeabilized in
Cytofix/Cytoperm solution (BD Biosciences) for 20min at 4°C
and then incubated with Ki67 Alexa647-conjugated monoclonal
antibody (Santa Cruz Biotechnology).
Analysis of Apoptosis by Annexin V
The extent of apoptosis in developing B cells was determined by
Annexin V staining in control and B cell-depleted mice 21 days
after B cell depletion, as described in Ref. (36). BM cells were
stained for B220, AA4.1, and IgM, followed by Annexin V (Biole-
gend, catalog number 640920) according to the manufacturer’s
protocol. Cells were then analyzed by flow cytometry.
Statistical Analysis of Experimental Data
We first tested whether there are significant differences in BrdU
labeling kinetics between the control and the depleted mice using
generalized linear model (GLM) repeated measures, a method
based on analysis of variance (ANOVA). Repeated measures
ANOVA is the equivalent of the one-way ANOVA, but is used
for related rather than independent measurements, and is the
extension of the dependent T-test. The test detects any overall dif-
ferences between related means. The dependent variables should
be continuous and the independent variables categorical. Each
dependent variable is represented by as many variables as there
are measurement times (e.g., Imm_2, Imm_4, and Imm_7 are the
BrdU fractions of labeled immature cells after 2, 4, and 7 days).
Mouse type is the categorical predictor variable. The analysis was
performed using the SPSS software.
Mathematical Models of B Cell
Subpopulations in the Spleen
We fit the BrdU data from control and B cell-depleted mice to
our mathematical models of B cell development in the BM and
maturation in the spleen. Themodel (Figure 1A) is fully described
by Eqs 1–5 below and has been constructed as follows. First, for
each population, we assigned a variable denoting the number of
cells in each population. The current data did not include pro-
and pre-B subpopulations; hence, we decided to include in the
model a population that combined both subsets, Boe, to repre-
sent the cells in the pro- and pre-B cell subsets that eventually
differentiate to the immature subset (henceforth called pro-/pre-B
cells). Transitional B cells aremodeled here as one subset, ignoring
their division into several maturation stages, because the focus
of this study is on B cell development in the BM. The current
data include the mature recirculating B cells subset in the BM, so
we added this subset to our mathematical model (Figure 1A; Eq.
3). The numbers of cells in the immature, mature recirculating,
transitional, and splenic mature subsets are represented by the
variables Bi, BMrec, Bt, and BMspl, respectively (Figure 2; Eqs 2–5).
Second, for each process in the model (that is, an arrow in
Figure 1), a rate parameterwas assigned; parameterswere denoted
by Greek letters to distinguish them from variables. For example,
Boe cells differentiate into the immature subset with a constant rate
denoted by δoe (per 6 h, which is our simulation time unit). Third,
the change in each population in each time unit (approximated
by the derivative of the corresponding variable representing the
number of the cells in this population) is given by a differential
equation. The general form of each differential equation is of the
form:
d (variable)
dx = entry+ proliferation  death  differentiation
where each of the four right-hand terms is either a constant or
a function of the variables and parameters. For example, the Boe
subpopulation is renewed from previous subsets at the constant
rate S. This subpopulation proliferates after passing heavy or light
chain rearrangements with a maximum rate γ (Figure 1A; Eq. 1).
The proliferation term in Eq. 1 is the product of the number of
cells that are able to proliferate (Boe), the maximum proliferation
rate (γ), and a so-called “logistic” limit on the proliferation, which
is a function that decreases with the available space for this pop-
ulation and is constructed as follows. The mature recirculating
subpopulation includes mature recirculating B cells that compete
with pro-/pre-B cells for survival niches (38), as do plasma cells.
Therefore, the carrying capacity parameter, K, that limits the
proliferation rate of the pro-/pre-B cell subpopulation includes
the total number of cells in both the pro-/pre-B and the mature
recirculating compartments (Eqs 1, 6, and 11), and the logistic
term is thus
h
1  (Boe+BMrec)K
i
.
The mature recirculating B cell subpopulation in this model
represents all the mature B cell subsets that re-enter into the
BM from the periphery. Other feedback onto the pro-/pre-B cell
division by any other cells, such as plasma cells, was not explicitly
modeled, since those cells were not measured; however, their
effect is implicitly modeled in part via the carrying capacity K,
such that a decrease in K would be interpreted as competition by
other cells for survival niches. Additionally, since the labeling data
did not include pro- and pre-B cell subpopulations, a regulation
of the source of pro-/pre-B cells by peripheral B cells or by other
cells in response to the depletion was not explicitly examined (see
Discussion).
Immature B cells either differentiate to BM mature cells at rate
δi_re, or emigrate from the BM to the spleen and differentiate
to transitional B cells at rate δi_t (Eqs 2–4). Transitional B cells
differentiate to splenic mature B cells at rate δt (Eqs 4 and 5). After
their maturation, splenic mature B cells can go back to the PB and
then to the mature recirculating population in the BM. The flow
of mature B cells from the spleen to the mature (recirculating)
population in the BM is represented by the parameter φS. The flow
in the opposite direction is represented by the parameter φBM (Eqs
3 and 5).
The death rates are denoted by μi, μt, and μrec for Bi, Bt,
and BMrec, respectively. The exit from the splenic mature B cell,
including death or transition to other organs, is denoted by
"spl. Based on previous studies, it is assumed that the transi-
tional subpopulation is not cycling (29, 39). We did not include
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FIGURE 1 |Model of B cell population dynamics in the bone marrow and spleen. (A) The model of maturing B-cell population dynamics in the bone marrow
and spleen is shown. All population processes – differentiation, proliferation, and death – are described by arrows. The rate of each process is given near the
corresponding arrow. S is the source of B lineage precursors (cells/6 h), parameters δ denote differentiation rates, μ mortality rates, γ proliferation rates, and φ flow
rates. (B) The model for labeling dynamics of developing B cells in the bone marrow assumes that cells in the unlabeled pro-/pre-B cell compartment move to the
corresponding labeled compartment upon dividing. The model also assumes that each labeled cell remains labeled for the duration of the experiment.
the possibility that peripheral B cell division is also a source
of the reconstitution, since a preliminary Ki67 staining showed
no evidence for cell division among mature splenic B cells in
either the depleted or control mice (data not shown). Thus,
the differences in the BrdU labeling kinetics between control
and depleted mice (Figure 3B) must be ascribed to differ-
ences in the entry-labeled cells from previous developmental
stages.
Thus, the model is completely described by the following
equations.
dBoe
dt = s+

γ

1  (Boe + BMrec)K

  δoe

Boe + δrBi (1)
dBi
dt = δoeBoe   Bi(μi + δi_t + δr + δi_re) (2)
dBMrec
dt = δi_reBi + ϕsBMspl   (μre + ϕBM)BMrec (3)
dBt
dt = δi_tBi   Bt(μt + δt) (4)
dBMspl
dt = δtBt + ϕBMBMrec   (ϕs + "spl)BMspl (5)
Modeling BrdU Labeling
The modeled subsets were divided into labeled and unlabeled
B cell populations, and the dynamics of these subsets are
given in Eqs 6–15 below. UBoe, UBi, UBt, UBMrec, and UBMspl
denote the numbers of unlabeled pro- and pre-, immature,
transitional, BM recirculating mature, and splenic mature B
cells, respectively (Eqs 6–10), and LBoe, LBi, LBt, LBMrec, and
LBMspl similarly denote the labeled subsets (Eqs 11–15). In these
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FIGURE 2 | Selective depletion of BM B cell subsets in an hCD20Tg
mouse. (A) BM cells from hCD20Tg mouse were stained for B220, IgM,
AA4.1, and hCD20. For analysis, viable lymphocyte were defined by forward
and side light scatter, and gates were set to analyze B220+/AA4.1+ early
developing B cells (pro-/pre-B and immature B cells) and to exclude
circulated B220+/AA4.1  and non-B lineage cells. Gated cells were
analyzed for expression of IgM and hCD20. (B) hCD20Tg mice were injected
with anti-hCD20 antibodies. Three days after injection, BM cells were stained
for B220 and IgM and analyzed for the following B cell subsets: pre-/pro-
(B220+/IgM ), immature (B220+/IgM+), and circulated mature
(B220hi/IgM+) B cells, relative to control hCD20Tg mice that were not treated.
The results shown are representative of three to four mice in each group.
equations, Boe=UBoe+ LBoe, Bi=UBi+ LBi, Bt=UBt+ LBt,
BMrec=UBMrec+ LBMrec, and BMspl=UBMspl+ LBMspl. Cells in
each unlabeled compartment move to the corresponding labeled
subset upon dividing (Figure 1B). When an unlabeled cell divides
during the labeling period, it leaves the unlabeled subpopu-
lation. Its two daughter cells both become labeled cells and
join the labeled subpopulation; hence, the number of unlabeled
proliferating cells entering the labeled subset is multiplied by a
factor of 2. We neglect BrdU toxicity (and thus assign the same
death rates to labeled and unlabeled cells), as in previous work
(28–31, 40); we found that when the BrdU experiment is very
short – as in this case, only 7 days – the latter assumption holds.We
also neglect labeling of the source cells, as in previous work (28).
dUBoe
dt = s 

γ

1  (Boe + BMrec)K

  δoe

UBoe + δrUBi
(6)
dUBi
dt = δoeUBoe   (μi + δi_t + δr + δi_re)UBi (7)
dUBMrec
dt = δi_reUBi + ϕsUBMspl   (μre + ϕBM)UBMrec (8)
dUBt
dt = δi_tUBi   (μt + δt)UBt (9)
dUBMspl
dt = δtUBt + ϕBMUBMrec   (ϕs + "spl)UBMspl (10)
dLBoe
dt = (2 Boe + LBoe)γ

1  (Boe + BMrec)K

  δoeLBoe + δrLBi (11)
dLBi
dt = δoeLBoe   (μi + δi_t + δr + δi_re)LBi (12)
dLBMrec
dt = δi_reLBi + ϕsLBMspl   (μre + ϕBM)LBMrec (13)
dLBt
dt = δi_tLBi   (μt + δt)LBt (14)
dLBMspl
dt = δtLBt + ϕBMLBMrec   (ϕs + "spl)LBMspl (15)
Model Simulation Program Description
The mathematical models were simulated and fitted to the exper-
imental data using a Matlab program. The program receives as
input the experimental data and the ranges of parameter values
within which the model should be run. In the simulation, we
tested only parameter combinations that gave total cell numbers
at steady state in each B cell subpopulation within a range of
total cells numbers measured experimentally. Since the BrdU
incorporation experiment in depletedmicewas done before B cells
were fully reconstituted, the cell populations have not yet reached
a steady state; hence, we used control mouse total cell numbers to
test parameter value sets for both mouse types, assuming that in
the depleted mice, after full reconstitution, the total cell numbers
would reach the same range as in the control mice.
For each parameter value set, the program integrates the model
equations as follows. The initial conditions are 0 cells in all pop-
ulations; labeling only starts after the populations have reached
a steady state in the control mice, and 34 days after depletion in
the depletion mice, as done in the experiments. For all runs, the
program calculates the value of the fit of themodel to the data (see
below) and outputs the parameter values, the total cell numbers
in each subpopulation, and the value of the fit. This process was
performed for each type of mice (depleted and control).
Model Parameter Estimation
For the purpose of finding parameter ranges, we used a Monte
Carlo class algorithm for sampling named the Latin hypercube
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FIGURE 3 | Control and hCD20-depleted mice (34days after depletion) were injected with BrdU and analyzed for BrdU labeling as detailed in Section
“Materials and Methods.” (A) BM and spleen cells from the control and the depleted mice were stained for IgM, AA4.1 and BrdU labeling. For analysis, viable
lymphocytes were defined by forward and side light scatter, and the relative BrdU labeling in BM immature (IgM+/AA4.1+) and mature-circulated (IgM+/AA4.1 ),
and in spleen transitional (IgM+/AA4.1+) and mature (IgM+/AA4.1 ) B cells was determined using gates set as shown (representative example). (B) BrdU labeling
kinetics in B cell-depleted (black, open circles for each single mouse and band for the mean value) and control (gray, filled triangles for each single mouse and band
for the mean value) mice. For total cell numbers, see Figure 4.
sampling (LHS) (41). LHS allows an unbiased estimate of the
average model output, with the advantage that it requires fewer
samples than simple random sampling to achieve the same
accuracy. In LHS, each parameter range is divided into N
equal probability intervals, and each interval is sampled exactly
once, and thus, N values are tested for each parameter. N
parameter combinations are set by assigning a value for each
parameter, selected from a random bin. Using LHS allows us
to run the simulation for a magnitude smaller number of
combinations (41).
We used maximum likelihood parameter estimation (MLE) to
determine the parameter values that maximize the probability
[likelihood (L)] of the data. The best fit parameter value set is
defined as the set of parameter values that yields the MLE for all
time points and for all experimental repetitions (mice).
Uncertainty Analysis
Input parameters for most mathematical models are not always
known with a sufficient degree of certainty because of natural
variation, error in measurements, or simply a lack of current
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techniques to measure them. The purpose of uncertainty analysis
is to quantify the degree of confidence in the existing experimental
data and parameter estimates. We furthermore used the profile
likelihood method to obtain confidence intervals (CI) for all the
mathematical model parameters (42–44). The likelihood ratio test
statistic (G2) of the hypothesis H0: θ= θ0 (where θ0 is a fixed
value of a specific parameter) equals the drop in 2lnL between
the “full” model and the reduced model with θ fixed at θ0, i.e.,
G2= 2[lnL(“Best fit”)  lnL(θ0)]. A 95% CI consists of those val-
ues of θ0 for which the test is not significant at a significance level
0.05; this is the case when G2 does not exceed 3.84 [the 95th per-
centile of the χ2(1) distribution]. In order to compare parameter
values between mouse types, we examined the parameter’s 95%
CI values. Very similar results were obtained when we used an
Akaike’s information criterion (AIC)-basedmethod, as in Ref. (30,
31, 34), indicating that these two methods for deriving parameter
CI are equivalent.
Sensitivity Analysis
Sensitivity analysis (SA) is another method for quantifying uncer-
tainty in any type of complex model. The objective of SA is to
identify critical inputs (parameters and initial conditions) of a
model and to quantify the extent to which input uncertainty
impacts model outcome(s). Linear regression analysis is a global
SA technique, which is implemented by the Monte Carlo simu-
lations. The linear regression analysis searched for linear trends
of the total numbers of cells in each subpopulation, which are
the model’s dependent variables, as function of the input parame-
ters. Two linear relationship measures are examined: the Pearson
correlation coefficient (R) and the partial correlation coefficients
(partial R or PRCCs). PRCCs appear to be, in general, the most
efficient and reliable among sampling-based indexes (45). PRCCs
provide a measure of monotonicity after removal of the linear
effects of all but one parameter. Here, we used a stepwise regres-
sion method in order to decide which of the input parameters are
critical to the model outcome(s). The parameters were included
in the regression analysis according to the change in the Pearson
correlation coefficient.
RESULTS
Faster BrdU Labeling of Mature B Cells in
Depleted Mice Compared with Controls
To determine whether B lymphopoiesis in the BM is regulated by
the size of the peripheral B cell compartment, we used hCD20Tg
mice where hCD20 is expressed exclusively on B lineage cells,
and administration of anti-hCD20 antibodies has been shown
to deplete the peripheral B cells, leaving all other cell lineages
intact (25). However, analysis of hCD20 expression during B
cell development revealed that hCD20 expression in these mice
starts only at the immature stage (IgM+), where about 40% of
the cells in this population, mostly late immature (as revealed
by high expression of IgM), express hCD20 (Figure 2A). Thus,
about 36% of the B220+/AA4.1+ developing B cells are immature
IgM+ cells, but only about 40% of them express hCD20 (14%,
Figure 2A) and can be targeted for depletion upon adminis-
tration of anti-hCD20 antibodies. The pro-/pre-B cells in these
mice do not express hCD20 (Figure 2A). In agreement with this,
administration of anti-hCD20 antibodies leads in the BM to the
rapid elimination of the hCD20+ subgroup of immature B cells
as well as circulated mature B cells but leaves the pro-/pre-B cell
compartment unchanged (Figure 2B). Thus, BM analysis 3 days
after treatment with anti-hCD20 antibodies revealed complete
depletion of mature-circulated B cells (B220hi/IgM+). Owing
to the antibody-mediated elimination of the hCD20+ cells in
the immature B cell compartment (Figure 2A), in the current
study, there was a reduction of about 50% in this compartment
(B220+/IgM+, from 15 to 7%, Figure 2B); this reflects a similar
reduction in cell numbers, since immature cell numbers in the
depleted mice did not significantly differ from those in control
mice (see below). There was no change in the size of the pro-
/pre-B cell compartment, which does not express hCD20; in both
control and depleted mice, it consisted of about 25% of B cells
(Figure 2B). We conclude that this selective depletion enables the
hCD20Tg mouse model to be used as an efficient model to test
whether B lymphopoiesis is homeostatically regulated in the most
physiological setup.
To explore whether B lymphopoiesis is homeostatically regu-
lated, hCD20Tg mice were treated with anti-hCD20 antibodies to
deplete B cells, thus generating conditions of peripheral “demand”
for B cells. Thirty-four days after depletion [when reconstitution
reached 50–60% (32)], we performed continuous in vivo BrdU
labeling of the depleted and control mice for 7 days, and analyzed
B cell subsets on days 2, 4, and 7 (n= 8 mice per time point).
In the BM, we defined immature B cells as IgM+/AA4.1+ and
mature-circulated B cells as IgM+/AA4.1 , and in the spleen,
we defined transitional B cells as IgM+/AA4.1+ and mature B
cells as IgM+/AA4.1  (Figure 3A). Gates were set for each subset
(Figure 3A), and the relative BrdU labeling in each subset was
determined (Figure 3B).
No differences between control and depleted mice were seen in
the immature (p= 0.391) and transitional B cell (p= 0.152) BrdU
labeling kinetics (Figure 3B). However, there were significant dif-
ferences in mature recirculating B cell labeling (p= 3.476E 007).
The fractions of labeled mature recirculating B cells in depleted
mice reached 60% by day 7, compared with 20% in the control
mice. Similar significant differences between control and depleted
mice were observed in the splenic mature B cell labeling kinetics
starting at day 4 (p= 1.806E 007), when the fractions of labeled
splenic mature B cells in depleted mice reached 25%, compared
with 10% in the control mice.
Higher Pro-/Pre-B Cell Proliferation in
Depleted Mice
We fitted our mathematical model of B cell BM development
and splenic maturation dynamics to the BrdU labeling data, and
compared the best fit parameter values and 95% CI (obtained
using the profile likelihood method) for the two mouse types
(Table 1). Parameter ranges that show no overlap between the
two mouse types – and hence are significantly different – are
highlighted in Table 1. Figure 4A shows the model’s fit to the
data with the best fit parameter value sets. The simulated total
cell numbers at each stage of development of control and depleted
micewerewithin the experimentally observed ranges (Figure 4B).
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TABLE 1 | The 95% CI for parameter values obtained in simulations of
labeling kinetics of control and depleted B cells.
Parameter Control Depleted
Best fit 95% CI Best fit 95% CI
γ 0.3 0.20–0.35 0.38 0.30–0.4
δoe 0.5 0.32–0.55 0.25 0.20–0.48
μi 0.10 0.02–0.2 0.53 0.2–0.75
δi_t 0.60 0.50–0.75 0.20 0.05–0.50
δi_re 0.19 0.10–0.22 0.158 0.10–0.20
Immature residence
time
1.13 1.1–1.5 1.13 1.1–1.6
μt 0.03 0.02–0.05 0.06 0.04–0.06
δt 0.03 0.014–0.04 0.005 0.005–0.04
Transitional
residence time
17.4 13.2–20.4 15.9 13.3–20.5
φBM 0.94 0.6–10.0 0.95 0.7–10.0
μrec 0.008 0.000–0.048 0.040 0.005–0.060
φs 0.03 0.015–0.030 0.019 0.014–0.024
"spl 0.008 0.008–0.009 0.018 0.014–0.022
All parameters are given in units of 1/6 h, and residence times are given in units of 6 h.
Cases where the ranges for control and depleted mice do not overlap are highlighted.
Some of the parameter values were found to be very similar in the control and depleted
cells, so we fixed them to constant values in the final series of runs. These constant values
were S=3 105 cells/6 h, K=6 106 cells, and δr=0.05, with all rates given as fraction
per 6 h.
The Boe subpopulation described above represents the pro- and
pre-B cell populations, that is, the proliferating subsets which dif-
ferentiate into immature B cells. Our simulation results reveal that
the proliferation rate of the Boe subpopulation in depleted mice is
higher than the same rate in the controlmice (Table 1; Figure 5A).
This difference is not significant as the CI overlap. However, when
we examine the interaction between the proliferation rate and the
differentiation from this subset, we see that the parameters for
each population form a different cluster, such that for all values
of the other parameters, the depleted mice always have a higher
proliferation rate with a lower differentiation rate than the control
mice (Figure 5B). A lower differentiation effectively increases
the cell residence time in the proliferating subset, thus further
increasing the overall cell production. We validated this result by
staining mouse BM cells with ki67, a cellular protein marker for
proliferation, in the pro-/pre-B compartment in young control
and B-cell-depleted mice (Figure 6A). The Ki67+ cell numbers
in the depleted mice were significantly higher than those in the
control mice (1.4 106 0.23 106 and 0.65 106 0.18 106,
respectively; p= 0.003) (Figure 6B). This result supports the
model’s prediction that reconstitution of BM B cell numbers after
a short depletion requires an increased proliferation of these cells.
Accelerated Immature B Cell Death and
Lower Differentiation Rates in Depleted
Mice
The most significant changes were observed in the immature cell
death rate and their differentiation rate into transitional B cells
(Table 1). In control mice, the majority of cells left the immature
compartment by differentiating into transitional B cells and fewer
by death. On the contrary, in the depleted mice, most of the
immature cells left this subset by dying, and fewer cells transited
FIGURE 4 | (A) BrdU labeling kinetics obtained by a simulation of the B cell
development model using the parameter value set that gave the best fit to the
data, shown (as lines) along with the data (symbols), for control (filled gray
triangles and gray lines), and depleted mice (open black circles and black
lines), in the immature, mature recirculating, transitional, and splenic mature B
cell subsets. The x-axis shows the time from the start of labeling. (B) The
ranges of total cell numbers in each B cell subset in the experimental
measurements of control and depleted mice and the corresponding
simulations [symbols and lines are as in (A)]. The x-axis shows the time from
the start of B cell depletion. The parameter values used in these simulations
are given in Table 1.
to the spleen (Table 1; Figures 5C–E). The differentiation rate
of immature B cells into the BM mature B cell subset and the
rate of their reflux back to the pro-/pre-B cell compartment were
the same in control and depleted mice. Differentiation and death
thus balanced each other, so that the residence time [defined as
1/(death rate+ exit rate)] in the immature B cell subpopulation
was the same in both control and depleted mice (Table 1). To
validate the increased immature B cell death in the depleted mice,
we stained mouse BM cells with Annexin V, which identifies
pro-apoptotic cells, and quantified this staining within the gated
immature B cell subset (B220+/AA4.1+/IgM+) in young controls
and B cell-depleted mice (Figure 6C). The frequency of Annexin
V-positive cells among immature B cells from depleted mice was
twofold larger relative to immature B cells from control mice,
whereas no difference in apoptosis was found in the pro-/pre-B
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FIGURE 5 | Box Plots of the parameter value distributions for each
rate parameter that was found to significantly differ between the
simulations of control and depleted mice. (A) The proliferation rate of the
Boe subpopulation. (B) The proliferation rate of the Boe subpopulation plotted
against its differentiation rate. (C) The rate of exit of immature B cell from the
BM. (D) Immature B cell death rate. (E) The rate of exit of immature B cell
from the BM plotted against their death rate. (F) Box Plots of the sources of
mature recirculating B cell subpopulations, that is, the total cell number
entering in each time step of 6 h. The white boxes are the flows from the
splenic mature B cell subpopulation (φsBMspl ) and the gray boxes are the
flows from the BM immature B cell subpopulation (δi_reBi). (G) The exit rate
from the splenic mature B cell subpopulation.
cell compartment (Figure 6D). This result supports the model’s
prediction that apoptosis is increased in immature B cells in
depleted mice.
Mature Recirculating B Cells in the BM
Probably Come from the Periphery
There were no significant differences in the input into, and the
exit rate from, the mature recirculating B cell subpopulation in
the BM marrow of depleted vs. control mice (Table 1). How-
ever, this is the first time that this subpopulation is included
in a mathematical model, so it was of interest to examine its
kinetic parameters. The source of the BM mature B cell subset is
uncertain, as we cannot distinguish experimentally between naïve
mature cells that have developed from the immature B cells in
the BM and cells that have emigrated from the periphery into the
BM. Our model predicts, however, that the most probable source
of this subpopulation in control mice is inflow from the splenic
mature subpopulation (3.3–8.7 105 cells/6 h), while the extent
of direct differentiation is almost an order of magnitude lower
(5.5 104–1.4 105 cells/6 h).
The flow rates from the splenic B cells to the BM were the
same in the control and depleted mice; however, the total number
of splenic mature cells that flow back into the BM is lower in
the latter mice due to the depletion (Figure 5F). Hence, the total
numbers of mature recirculating B cells are lower in the depleted
mice compared to the controls, in both the experimental data and
the model simulation (Figure 4B). Finally, the exit rate from the
splenic mature B cell subpopulation was higher in the depleted
compare to control mice (Table 1; Figure 5G), possibly due to
demand from other peripheral lymphoid tissues.
Parameter Sensitivity Analysis
We used linear regression analysis to determine which parameters
are critical for the model outcome, that is, the total cell numbers
in each subpopulation. Along with the kinetic rates, we included
the mouse type (control or depleted) as a parameter. The critical
parameters determining immature cell numbers were found to
be mouse type, all the exit rates from this subpopulation and
the proliferation rate of the pro-/pre-B subpopulation (Table 2).
These parameters together explain 98% of the variance in imma-
ture total cell numbers (R2= 0.98). Increasing the pro-/pre-B
proliferation rate (positive partial correlation) or decreasing any of
the immature B cell exit rates (negative partial correlation) would
increase the total cell numbers in the immature compartment
(Table 2), as expected. The positive partial correlation between
mouse type and immature B cell numbers suggests that the deple-
tion results in slightly increased cell numbers in the immature B
cell compartment.
The critical parameters affecting transitional B cell numbers
were, as expected, the rate of immature B cell differentiation into
this subset, all the other exit rates from the immature B cell subset
(as these processes compete with exit to the periphery), the exit
rate from this subpopulation, and the proliferation rate of the
pro-/pre-B subpopulation, through its effect on immature B cell
numbers (Table 2). These parameters together explain 97% of
the variance in transitional B cell numbers. Increasing pro-/pre-B
proliferation and the immature to transitional differentiation rate,
or decreasing any of the other exit rates from the immature and
transitional subpopulations, would increase the cell numbers in
the transitional compartment.
Cell numbers in the BM mature recirculating B cell subset
were similarly affected by mouse type, the immature B cell rate
of differentiation into this subset, the proliferation rate of the
pro-/pre-B subpopulation, the inflow from the periphery into
this compartment, and the flow out of this subpopulation to the
periphery (Table 2). These parameters together explain 95% of
the variance in BM mature B cell numbers. When the rates of
pro-/pre-B proliferation, immature B cell differentiation or inflow
from the periphery increase, or the flow of mature B cells from
the BM to the periphery decreases, the BMmature B cell numbers
Frontiers in Immunology | www.frontiersin.org March 2016 | Volume 7 | Article 779
Shahaf et al. Homeostatic Feedback in B Lymphopoiesis
FIGURE 6 | BM cells from control and hCD20-depleted mice (34days after depletion) were stained for B220 IgM AA4.1 and Ki67 or Annexin V. For
analysis, viable lymphocytes were defined by forward and side light scatter and the relative Ki67 or Annexin V staining in pro-/pre-B (B220+/AA4.1+/IgM ) or
immature (B220+/AA4.1+/IgM+) B cell subsets was determined using gates set as shown in Figure 2A. (A) Histograms showing Ki67 expression in the gated
pro-/pre- and immature B cell subsets in the control and depleted mice (representative example). (B) Ki67+ cell numbers in the pro-/pre-B cell compartment in control
and B cell-depleted mice. (C) Histograms showing Annexin V expression in the pro-/pre-B and immature cell subsets in control and depleted mice (representative of
four mice in each group). (D) Percentages of Annexin V+ cells in the pro-/pre-B and immature B cell compartments in control and B cell-depleted mice.
increase. The negative partial correlation betweenmouse type and
BM mature B cell numbers suggests that the depletion slightly
decreases these cell numbers.
Finally, the critical parameters affecting splenic mature B cell
numbers are the rate of transitional cell maturation to this subset
and the death rates of both the immature and transitional B
cell subpopulations (Table 2). These parameters together explain
96% of the variance in splenic mature B cell numbers. When
transitional cell maturation increases, or any of these death rates
decreases, the splenicmature B cell numbers increase, as expected.
DISCUSSION
Cellular homeostasis of the peripheral B cell compartment in the
BM is maintained by a balance between cell production and cell
death (13). In the present study, we have tested the previously
suggested (14, 15), but yet not proven concept that, similar to other
hematopoietic cell lineages (46–48), B lymphopoiesis is regulated
by the size of the peripheral B cell compartment. We have used
the human CD20Tg mouse model, where peripheral B cells can
be specifically eliminated using anti-CD20 antibodies with no
residual effect on other cell populations, in order to find whether
mature B cells affect the homeostasis of developing B cells in the
BM (25). We used flow cytometric analysis, BrdU labeling, and
our mathematical models of B cells development and maturation,
to compare between B cell population dynamics in short-term
(34 days) depleted mice and in control mice.
The mathematical model results suggested that in depleted
mice, pro-/pre-B cells have a higher proliferation rate
and a lower differentiation rate, relative to control mice
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TABLE 2 | Sensitivity analysis by linear regression.
Model outcome R R2 Critical parameters Partial R
Immature cell numbers (Bi) 0.99 0.98 Mouse type 0.81
δi_re  0.77
μi  0.90
δi_t  0.89
γ 0.61
Transitional cell numbers 0.98 0.97 δi_t 0.69
(Bt ) γ 0.50
μi  0.62
δi_re  0.26
μt  0.62
δt  0.59
BM recirculating mature 0.97 0.95 Mouse type  0.88
cell numbers (BMrec) δi_re 0.74
γ 0.59
φBM  0.54
φs 0.47
Splenic mature cell 0.98 0.96 δt 0.40
numbers (BMspl ) μi  0.81
μt  0.53
(Table 1; Figures 5A,B). Since the effect of lowering the
differentiation rate is to increase the residence time of B cells
in this compartment, thus giving them more opportunities
to divide, the net effect of these two changes is to increase
overall B cell production. This finding was validated by ki67
staining (Figure 6), supporting the conclusion that depletion
of transitional and mature B cells results in increased B cell
production in the BM. Importantly, we showed above that the
pro-/pre-B cells in this mouse model do not express hCD20, and
therefore were not affected by the anti-hCD20 antibody. This
suggests that the increased proliferative response we found in this
cell population is driven by the alteration of B cell homeostasis
caused by the selective depletion of immature and peripheral B
cells and not due to a general elimination of all B cell subsets.
To characterize homeostatic effects, they must be measured
upon alteration of homeostasis under highly physiological con-
ditions. We believe the hCD20Tg model is most appropriate, as it
allows selective depletion only of peripheral mature B cells with
no residual effects on other cell lineages (25). Studies with other
lymphopenic mouse models, such as BAFF-receptor mutants,
CD19 /  and CD74 / , revealed no apparent effect on B cell
generation (49–51). However, in these mice, B cell generation
was determined based on quantification of B cell subsets at
a single time point, rather than by kinetic measurements that
would enable the calculation of proliferation and death rates, as
we have done here. Nevertheless, we have recently shown that
B cell lymphopenia in these mouse models prevents the age-
associated decline of B lymphopoiesis that is otherwise devel-
oping in aged normal mice (32, 34), and that B cell depletion
in normal old mice reactivates B lymphopoiesis in the BM (32).
These findings, in our view, strongly support the existence of
a feedback mechanism by which the peripheral B cell com-
partment regulates B lymphopoiesis. The nature of this home-
ostatic regulation is yet elusive. It is tempting to speculate that
a soluble factor that is secreted by peripheral B cells, or other
cells that somehow sense B cells numbers, can suppress/stimulate
B lymphopoiesis in the BM, similarly to the role of erythropoi-
etin in maintaining red blood cell homeostasis. However, sim-
pler mechanisms may exist, such as competition for BM sur-
vival niches or contact-mediated effects, as we have proposed
(52–54). Further studies are needed in order to identify this
mechanism.
The current model did not address the question of whether
homeostatic regulatory mechanisms also affect the entry of
hemopoietic stem cells into the pro-/pre-B cell compartment for
two reasons. First, the experimental data did not cover these
subsets and second, the effect of increased entry into this com-
partment on subsequent compartments would be similar to that
of increased proliferation. Once the nature of the homeostatic reg-
ulation mechanism is elucidated, however, it would be interesting
to examine its effect, if any, on stem cell differentiation into the B
cell lineage.
The model also did not address the possibility that any other
cell subsets affect the dynamics of B cell development in the BM,
because the depletion only affects the B cell compartment (25),
and thus, we could not use the depletion experiments to elucidate
the effects of other cell subsets. However, our results enable us to
exclude the possibility of competition for BM survival niches by
other cells – such as plasma cells, whichmight have been indirectly
affected by B cell depletion – because such competition would
have changed K, the carrying capacity limiting the proliferation
in the pro-/pre-B cell compartment. However, no such difference
in K between control and depleted mice was obtained in fitting
the model to the experimental data.
In addition to the effects on the pro-/pre-B cell compartment,
the modeling results revealed strong effects of depletion on the
immature subset. These include both an accelerated immature
B cell death and a lower rate of differentiation of immature to
transitional B cells in depleted mice compared to the rates in
control mice, although the residence times in these compart-
ments were the same in both control and depleted mice (Table 1;
Figures 5C–E). As a result, the total cell numbers of the more
developed stages are lower in depleted mice. As the increased
immature cell death during recovery from depletion was sur-
prising, we validated this result experimentally. The frequency of
AnnexinV-positive cells among immature B cells in depletedmice
was twofold larger than that in control mice (Figure 6D), validat-
ing the model’s prediction. It is plausible that when cells numbers
are reduced by depletion, there is less competition for binding self-
antigens, so that negative selection pressures may increase; if true,
this would explain the increased death and reduced differentiation
of immature B cells.
Finally, our modeling results predict that the source of the
mature B cells in the BM is probably an inflow from the periphery
to the BM, and that it is less likely that this population develops
directly from the immature B cells subpopulation in the BM. Thus,
the mature B cells in the BM are, indeed, recirculating cells and
not BM-resident. In situations where peripheral B cells numbers
increase – as in aging – then this predicts that mature B cell
recirculation to the BM, and homeostatic pressures on developing
B cells in the BM, will also increase.
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Our results suggest that the homeostatic pressures exerted
by increased numbers of peripheral B cells, as in lymphomas,
in autoimmune diseases where the B cell population includes
expanded self-antigen-specific B cell clones, or in the elderly
where peripheral B cells include high numbers of long-lived
antigen experienced B cells, probably affect B cell production in
all these situations. Rituximab, a chimeric monoclonal antibody
directed toward the pan-B cell surface marker CD20, is widely
used in the treatment of B cell malignancies and autoimmune dis-
eases, with very promising results (55). In this study, we simulated
the Rituximab B cell depletion treatment and defined its effect
on B cell production dynamics. The increased B cell production
observed in depleted mice indicates that, indeed, the BM mature
B cells are being replaced during post-depletion recovery by a
variety of newly generated cells. This may contribute to better
immune recovery in those patients in whom treatment has been
completed and the B cell compartment regenerated, as the new
repertoire would be “rejuvenated” by the treatment.
AUTHOR CONTRIBUTIONS
DM and RM designed the study. SZ-R performed most of the
experiments andDB performed some experiments. GS performed
all the modeling, statistical analysis, and wrote the paper. DM and
RM critically read and finalized the paper.
ACKNOWLEDGMENTS
This study was supported by the Israel Science Founda-
tion’s “First” program (grant No. 1362/11), The German-
Israel Foundation for Scientific Research and Development
(grant no. 1121-133.11/2010); grants from The Wolens Geron-
tology Research Fund and The Colleck Research Fund (to
DM); and a grant from the BIU-Sheba joint research fund
(to RM). Dr. Gitit Lavy-Shahaf was supported by a FLARE-
2 (Future Leaders in Aging Research in Europe) Postdoctoral
Fellowship.
REFERENCES
1. RajewskyK.Clonal selection and learning in the antibody system.Nature (1996)
381:751–8. doi:10.1038/381751a0
2. Edry E, Melamed D. Receptor editing in positive and negative selection of
B lymphopoiesis. J Immunol (2004) 173:4265–71. doi:10.4049/jimmunol.173.
7.4265
3. Melchers F, Rolink A, Grawunder U, Winkler TH, Karasuyama H, Ghia P,
et al. Positive and negative selection events during B lymphopoiesis. Curr Opin
Immunol (1995) 7:214–27. doi:10.1016/0952-7915(95)80006-9
4. Hardy RR, Carmack CE, Shinton SA, Kemp JD, Hayakawa K. Resolution and
characterization of pro-B and pre-pro-B cell stages in normal mouse bone
marrow. J Exp Med (1991) 173:1213–25. doi:10.1084/jem.173.5.1213
5. Rolink AG, Schaniel C, Andersson J, Melchers F. Selection events operating
at various stages in B cell development. Curr Opin Immunol (2001) 13:202–7.
doi:10.1016/S0952-7915(00)00205-3
6. Monroe JG. ITAM-mediated tonic signalling through pre-BCR and BCR com-
plexes. Nat Rev Immunol (2006) 6:283–94. doi:10.1038/nri1808
7. Carsetti R, Kohler G, Lamers MC. Transitional B-cells are the target of negative
selection in the B-cell compartment. J Exp Med (1995) 181:2129–40. doi:10.
1084/jem.181.6.2129
8. Osmond DG. Proliferation kinetics and the lifespan of B cells in central and
peripheral lymphoid organs.Curr Opin Immunol (1991) 3:179–85. doi:10.1016/
0952-7915(91)90047-5
9. Nossal GJ. Negative selection of lymphocytes. Cell (1994) 76:229–39. doi:10.
1016/0092-8674(94)90331-X
10. Shivtiel S, Leider N, Sadeh O, Kraiem Z, Melamed D. Impaired light chain
allelic exclusion and lack of positive selection in immature B cells expressing
incompetent receptor deficient of CD19. J Immunol (2002) 168:5596–604. doi:
10.4049/jimmunol.168.11.5596
11. Cyster JG, Goodnow CC. Antigen-induced exclusion from follicles and anergy
are separate and complementary processes that influence peripheral B cell fate.
Immunity (1995) 3:691–701. doi:10.1016/1074-7613(95)90059-4
12. Scholz JL, Crowley JE, Tomayko MM, Steinel N, O’Neill PJ, Quinn WJ, et al.
BLyS inhibition eliminates primary B cells but leaves natural and acquired
humoral immunity intact. Proc Natl Acad Sci U S A (2008) 105:15517–22.
doi:10.1073/pnas.0807841105
13. Crowley JE, Scholz JL, Quinn WJ III, Stadanlick JE, Treml JF, Treml LS, et al.
Homeostatic control of B lymphocyte subsets. Immunol Res (2008) 42:75–83.
doi:10.1007/s12026-008-8036-y
14. Osmond DG, Fahlman MT, Fulop GM, Rahal DM. Regulation and localiza-
tion of lymphocyte production in the bone marrow. Ciba Found Symp (1981)
84:68–86.
15. Park YH, Osmond DG. Post-irradiation regeneration of early B-lymphocyte
precursor cells in mouse bone marrow. Immunology (1989) 66:343–7.
16. Cancro MP, Allman DM, Hayes CE, Lentz VM, Fields RG, Sah AP, et al.
B cell maturation and selection at themarrow-periphery interface. Immunol Res
(1998) 17:3–11. doi:10.1007/BF02786425
17. Agenès F. B lymphocyte life span, rate of division and differentiation are
regulated by total cell number. Eur J Immunol (2003) 33:1063–9. doi:10.1002/
eji.200323550
18. Le Bouteiller P, Asherson G, Edwards A. Control of B-cell maturation in mice.
I. Increased B-cell maturation in vitro by bone marrow protected during whole
body irradiation. Immunology (1981) 42:267.
19. Fulop G, Pietrangeli C, Osmond D. Regulation of bone marrow lympho-
cyte production: IV. Altered kinetic steady state of lymphocyte produc-
tion after chronic changes in exogenous stimuli. Exp Hematol (1986) 14:
27–34.
20. Opstelten D, Osmond DG. Regulation of pre-B cell proliferation in bone
marrow: immunofluorescence stathmokinetic studies of cytoplasmic p chain-
bearing cells in anti-IgM-treated mice, hematologically deficient mutant mice
andmice given sheep red blood cells. Eur J Immunol (1985) 15:599–605. doi:10.
1002/eji.1830150613
21. Agenes F, Rosado MM, Freitas AA. Independent homeostatic regulation
of B cell compartments. Eur J Immunol (1997) 27:1801–7. doi:10.1002/eji.
1830270731
22. Gaudin E, Rosado M, Agenes F, McLean A, Freitas AA. B-cell homeostasis,
competition, resources, and positive selection by self-antigens. Immunol Rev
(2004) 197:102–15. doi:10.1111/j.0105-2896.2004.0095.x
23. Reid G, Osmond D. B lymphocyte production in the bone marrow of mice with
X-linked immunodeficiency (xid). J Immunol (1985) 135:2299–302.
24. Sundblad A, Marcos M, Huetz F, Freitas A, Heusser C, Portnoi D, et al.
Normal serum immunoglobulins influence the numbers of bone marrow pre-
B and B cells. Eur J Immunol (1991) 21:1155–61. doi:10.1002/eji.1830210510
25. Ahuja A, Shupe J, Dunn R, Kashgarian M, Kehry MR, Shlomchik MJ. Deple-
tion of B cells in murine lupus: efficacy and resistance. J Immunol (2007)
179:3351–61. doi:10.4049/jimmunol.179.5.3351
26. Asquith B, Debacq C, Macallan DC, Willems L, Bangham CR. Lympho-
cyte kinetics: the interpretation of labelling data. Trends Immunol (2002)
23:596–601. doi:10.1016/S1471-4906(02)02337-2
27. Borghans JA, De Boer RJ. Quantification of T-cell dynamics: from telomeres to
DNA labeling. Immunol Rev (2007) 216:35–47. doi:10.1111/j.1600-065X.2007.
00497.x
28. Mehr R, Shahaf G, Sah A, Cancro M. Asynchronous differentiation models
explain bone marrow labeling kinetics and predict reflux between the pre- and
immature B cell pools. Int Immunol (2003) 15:301–12. doi:10.1093/intimm/
dxg025
29. Shahaf G, Allman D, Cancro MP, Mehr R. Screening of alternative models for
transitional B cell maturation. Int Immunol (2004) 16:1081–90. doi:10.1093/
intimm/dxh109
Frontiers in Immunology | www.frontiersin.org March 2016 | Volume 7 | Article 7712
Shahaf et al. Homeostatic Feedback in B Lymphopoiesis
30. Shahaf G, CancroMP,Mehr R. Kinetic modeling reveals a common death niche
for newly formed and mature B cells. PLoS One (2010) 5:e9497. doi:10.1371/
journal.pone.0009497
31. Shahaf G, Gross AJ, Sternberg-SimonM, Kaplan D, DeFranco AL, Mehr R. Lyn
deficiency affects B-cell maturation as well as survival. Eur J Immunol (2012)
42:511–21. doi:10.1002/eji.201141940
32. Keren Z, Naor S, Nussbaum S, Golan K, Itkin T, Sasaki Y, et al. B-cell depletion
reactivates B lymphopoiesis in the BM and rejuvenates the B lineage in aging.
Blood (2011) 117:3104–12. doi:10.1182/blood-2010-09-307983
33. Edry E, Koralov SB, Rajewsky K, Melamed D. Spontaneous class switch recom-
bination in B cell lymphopoiesis generates aberrant switch junctions and is
increased after VDJ rearrangement. J Immunol (2007) 179:6555–60. doi:10.
4049/jimmunol.179.10.6555
34. Keren Z, Averbuch D, Shahaf G, Zisman-Rozen S, Golan K, Itkin T, et al.
Chronic B cell deficiency from birth prevents age-related alterations in the B
lineage. J Immunol (2011) 187:2140–7. doi:10.4049/jimmunol.1100999
35. Tabibian-Keissar H, Hazanov L, Schiby G, Rosenthal N, Rakovsky A, Michaeli
M, et al. Aging affects B-cell antigen receptor repertoire diversity in primary and
secondary lymphoid tissues. Eur J Immunol (2016) 46(2):480–92. doi:10.1002/
eji.201545586
36. Koralov SB, Muljo SA, Galler GR, Krek A, Chakraborty T, Kanellopoulou
C, et al. Dicer ablation affects antibody diversity and cell survival in the B
lymphocyte lineage. Cell (2008) 132:860–74. doi:10.1016/j.cell.2008.02.020
37. Sugalski JM, Rodriguez B, Moir S, Anthony DD. Peripheral blood B cell sub-
set skewing is associated with altered cell cycling and intrinsic resistance to
apoptosis and reflects a state of immune activation in chronic hepatitis C virus
infection. J Immunol (2010) 185:3019–27. doi:10.4049/jimmunol.1000879
38. Fairfax KA, Kallies A, Nutt SL, Tarlinton DM. Plasma cell development: from
B-cell subsets to long-term survival niches. Semin Immunol (2008) 20(1):49–58.
doi:10.1016/j.smim.2007.12.002
39. AllmanD, Lindsley RC, DeMuthW, RuddK, Shinton SA, Hardy RR. Resolution
of three nonproliferative immature splenic B cell subsets reveals multiple selec-
tion points during peripheral B cell maturation. J Immunol (2001) 167:6834–40.
doi:10.4049/jimmunol.167.12.6834
40. Shahaf G, Johnson K, Mehr R. B cell development in aging mice: lessons from
mathematical modeling. Int Immunol (2006) 18:31–9. doi:10.1093/intimm/
dxh346
41. Marino S, Hogue IB, Ray CJ, Kirschner DE. A methodology for performing
global uncertainty and sensitivity analysis in systems biology. J Theor Biol
(2008) 254:178–96. doi:10.1016/j.jtbi.2008.04.011
42. Kreutz C, Raue A, Timmer J. Likelihood based observability analysis and
confidence intervals for predictions of dynamic models. BMC Syst Biol (2012)
6:120. doi:10.1186/1752-0509-6-120
43. Raue A, Kreutz C, Maiwald T, Bachmann J, Schilling M, Klingmüller U, et al.
Structural and practical identifiability analysis of partially observed dynamical
models by exploiting the profile likelihood. Bioinformatics (2009) 25:1923–9.
doi:10.1093/bioinformatics/btp358
44. Venzon D, Moolgavkar S. A method for computing profile-likelihood-based
confidence intervals. Appl Stat (1988) 37:87–94. doi:10.2307/2347496
45. Saltelli A, Marivoet J. Non-parametric statistics in sensitivity analysis for
model output: a comparison of selected techniques. Reliab Eng Syst Saf (1990)
28:229–53. doi:10.1016/0951-8320(90)90065-U
46. De la Rubia J, Díaz MA, Verdeguer A, Pascual MJ, Arbona C, Arrieta R,
et al. Donor age-related differences in PBPC mobilization with rHuG-CSF.
Transfusion (2001) 41:201–5. doi:10.1046/j.1537-2995.2001.41020201.x
47. Eaton SM, Maue AC, Swain SL, Haynes L. Bone marrow precursor cells from
aged mice generate CD4 T cells that function well in primary and memory
responses. J Immunol (2008) 181:4825–31. doi:10.4049/jimmunol.181.7.4825
48. Peter Klinken S. Red blood cells. Int J Biochem Cell Biol (2002) 34:1513–8.
doi:10.1016/S1357-2725(02)00087-0
49. Rickert RC, Rajewsky K, Roes J. Impairment of T-cell-dependent B-cell
responses and B-1 cell development in CD19-deficient mice. Nature (1995)
376:352–5. doi:10.1038/376352a0
50. Sasaki Y, Casola S, Kutok JL, Rajewsky K, Schmidt-Supprian M. TNF family
member B cell-activating factor (BAFF) receptor-dependent and -independent
roles for BAFF in B cell physiology. J Immunol (2004) 173:2245–52. doi:10.4049/
jimmunol.173.4.2245
51. Shachar I, Flavell RA. Requirement for invariant chain in B cell maturation and
function. Science (1996) 274:106–8. doi:10.1126/science.274.5284.106
52. Mehr R, Melamed D. Reversing B cell aging. Aging (Albany NY) (2011)
3(4):438–43.
53. Melamed D. Homeostatic regulation of aging and rejuvenation in the B lin-
eage cells. Crit Rev Immunol (2013) 33:41–56. doi:10.1615/CritRevImmunol.
2013006907
54. Melamed D, Scott DW. Aging and neoteny in the B lineage. Blood (2012)
120:4143–9. doi:10.1182/blood-2012-07-444711
55. Leandro MJ, Cambridge G, Ehrenstein MR, Edwards JCW. Reconstitution
of peripheral blood B cells after depletion with rituximab in patients with
rheumatoid arthritis. Arthritis Rheum (2006) 54:613–20. doi:10.1002/art.21617
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Copyright © 2016 Shahaf, Zisman-Rozen, Benhamou, Melamed and Mehr. This is an
open-access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original publica-
tion in this journal is cited, in accordance with accepted academic practice. No use,
distribution or reproduction is permitted which does not comply with these terms.
Frontiers in Immunology | www.frontiersin.org March 2016 | Volume 7 | Article 7713
